Crinetics Pharmaceuticals, Inc. 4 SEC Filings

Filed On	Filing
01 Sep 2026	Form 4: Wierenga Wendell, Director Returned 122,071 shares to the issuer ($10.4M) · Disposed of 110,080 Stock Option (Right to Buy) (Disposition to Issuer) ($6.5M)
01 Sep 2026	Form 4: Vivaldi Coelho Rogerio, Director Returned 19,225 shares to the issuer ($1.63M) · Disposed of 93,830 Stock Option (Right to Buy) (Disposition to Issuer) ($5.23M)
01 Sep 2026	Form 4: Okey Stephanie, Director Returned 12,325 shares to the issuer ($1.05M) · Disposed of 105,080 Stock Option (Right to Buy) (Disposition to Issuer) ($6.09M)
01 Sep 2026	Form 4: Nichols Weston, Director Returned 22,225 shares to the issuer ($1.89M) · Disposed of 110,080 Stock Option (Right to Buy) (Disposition to Issuer) ($6.5M)
01 Sep 2026	Form 4: Fust Matthew K, Director Returned 28,761 shares to the issuer ($2.44M) · Disposed of 52,172 Stock Option (Right to Buy) (Disposition to Issuer) ($2.83M)
01 Sep 2026	Form 4: Deardorf Caren, Director Returned 22,225 shares to the issuer ($1.89M) · Disposed of 89,455 Stock Option (Right to Buy) (Disposition to Issuer) ($5.25M)
01 Sep 2026	Form 4: Bedrosian Camille L, Director Returned 22,225 shares to the issuer ($1.89M) · Disposed of 110,080 Stock Option (Right to Buy) (Disposition to Issuer) ($6.68M)
01 Sep 2026	Form 4: Kalofonos Isabel, Chief Commercial Officer Returned 35,669 shares to the issuer ($3.03M) · Disposed of 152,500 Stock Option (Right to Buy) (Disposition to Issuer) ($6.6M)
01 Sep 2026	Form 4: Betz Stephen F., Chief Scientific Officer Returned 137,936 shares to the issuer ($11.7M) · Disposed of 767,304 Stock Option (Right to Buy) (Disposition to Issuer) ($48M)
01 Sep 2026	Form 4: Schilke Tobin, Chief Financial & Infra. Ofcr. Returned 79,427 shares to the issuer ($6.75M) · Disposed of 130,000 Stock Option (Right to Buy) (Disposition to Issuer) ($6.16M)
01 Sep 2026	Form 4: Struthers Richard Scott, Director Returned 1,402,911 shares to the issuer ($119M) · Disposed of 1,939,822 Stock Option (Right to Buy) (Disposition to Issuer) ($110M)
24 Aug 2026	Form 4: Schilke Tobin, Chief Financial & Infra. Ofcr. Received 471 shares as a grant or award
11 Aug 2026	Form 4: Struthers Richard Scott, Director Received 19,928 shares by exercise or conversion ($400K)
07 Jul 2026	Form 4: Vivaldi Coelho Rogerio, Director Sold 3,000 shares ($120K)
22 Jun 2026	Form 4: Vivaldi Coelho Rogerio, Director Received 5,925 shares as a grant or award · Granted 9,730 Stock Option (Right to Buy)
22 Jun 2026	Form 4: Deardorf Caren, Director Received 5,925 shares as a grant or award · Granted 9,730 Stock Option (Right to Buy)
22 Jun 2026	Form 4: Fust Matthew K, Director Received 5,925 shares as a grant or award · Granted 9,730 Stock Option (Right to Buy)
22 Jun 2026	Form 4: Nichols Weston, Director Received 5,925 shares as a grant or award · Granted 9,730 Stock Option (Right to Buy)
22 Jun 2026	Form 4: Wierenga Wendell, Director Received 5,925 shares as a grant or award · Granted 9,730 Stock Option (Right to Buy)
22 Jun 2026	Form 4: Okey Stephanie, Director Received 5,925 shares as a grant or award · Granted 9,730 Stock Option (Right to Buy)

Comments